Bridger Management, LLC
- SEC CIK
- 0001166309
- Latest filing
- Aug 17, 2026
Holdings in Q3 2023
Holdings as of Sep 30, 2023, filed Mar 25, 2024. Long positions only; changes compare share counts with Q2 2023.
- Positions
- 32
- +2 vs. Q2 2023
- Portfolio value
- $272.9M
- −$28.6M (−9.5%) vs. Q2 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| UBERUber Technologies, Inc | Stock | 509,357 | $23.4M | 8.6% | −285,200−35.9% | Reduced | History |
| CZRCaesars Entertainment, Inc. | COM | 427,925 | $19.8M | 7.3% | −36,600−7.9% | Reduced | History |
| MLCOMelco Resorts & Entertainment LTD | ADR | 1,965,122 | $19.4M | 7.1% | 00.0% | Unchanged | History |
| CHTRCharter Communications, Inc. | CL A | 44,113 | $19.4M | 7.1% | −6,800−13.4% | Reduced | History |
| GDDYGoDaddy Inc. | CL A | 236,244 | $17.6M | 6.4% | −33,559−12.4% | Reduced | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,500,000 | $15.3M | 5.6% | 00.0% | Unchanged | History |
| LLYEli Lilly & Co | Stock | 28,076 | $15.1M | 5.5% | 00.0% | Unchanged | History |
| MSMorgan Stanley | Stock | 181,914 | $14.9M | 5.4% | 00.0% | Unchanged | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 42,400 | $14.7M | 5.4% | 00.0% | Unchanged | History |
| BBWIBath & Body Works, Inc. | COM | 396,327 | $13.4M | 4.9% | +24,227+6.5% | Added | History |
| USFDUS Foods Holding Corp. | COM | 312,331 | $12.4M | 4.5% | +65,900+26.7% | Added | History |
| BIIBBiogen Inc. | COM | 34,261 | $8.81M | 3.2% | −12,372−26.5% | Reduced | History |
| CCKCrown Holdings, Inc. | COM | 99,000 | $8.76M | 3.2% | +43,900+79.7% | Added | History |
| EDREndeavor Group Holdings, Inc. | CL A COM | 436,860 | $8.69M | 3.2% | +436,860 | New | History |
| ALCAlcon Inc | Stock | 101,227 | $7.80M | 2.9% | −80,750−44.4% | Reduced | History |
| IMGNImmunoGen, Inc. | COM | 467,220 | $7.41M | 2.7% | 00.0% | Unchanged | History |
| DCBODocebo Inc. | COM | 156,892 | $6.36M | 2.3% | +18,300+13.2% | Added | History |
| AKROAkero Therapeutics, Inc. | COM | 101,500 | $5.13M | 1.9% | +101,500 | New | History |
| QTRXQuanterix Corp | COM | 154,900 | $4.20M | 1.5% | 00.0% | Unchanged | History |
| BLCOBausch & Lomb Corp | COMMON SHARES | 245,431 | $4.16M | 1.5% | 00.0% | Unchanged | History |
| SHCSotera Health Co | COM | 260,400 | $3.90M | 1.4% | 00.0% | Unchanged | History |
| THCTenet Healthcare Corp | COM NEW | 58,500 | $3.85M | 1.4% | +58,500 | New | History |
| DXCMDexcom Inc | COM | 38,800 | $3.62M | 1.3% | +38,800 | New | History |
| CRLCharles River Laboratories International, Inc. | COM | 17,600 | $3.45M | 1.3% | +17,600 | New | History |
| KNFKnife River Corp | Stock | 68,199 | $3.33M | 1.2% | 00.0% | Unchanged | History |
| WRACWilliams Rowland Acquisition Corp. | COM | 297,000 | $3.11M | 1.1% | 00.0% | Unchanged | History |
| PODDInsulet Corp | Stock | 11,800 | $1.88M | 0.7% | +11,800 | New | History |
| GOOGLAlphabet Inc. | Stock | 13,900 | $1.82M | 0.7% | 00.0% | Unchanged | History |
| TOSTToast, Inc. | Stock | 52,692 | $986.9K | 0.4% | 00.0% | Unchanged | History |
| QUREuniQure N.V. | SHS | 12,009 | $80.6K | <0.1% | −98,991−89.2% | Reduced | History |
| SRZNSurrozen, Inc. | COM | 61,699 | $30.2K | <0.1% | 00.0% | Unchanged | History |
| Surrozen, Inc.86889P117 | *W EXP 08/01/203 | 466,666 | $19.2K | <0.1% | 00.0% | Unchanged | – |
Sold out since Q2 2023 (4)
Positions held at the end of Q2 2023 that are gone from this filing.
| Security | Class | Shares in Q2 2023 | Value in Q2 2023 | % of portfolio in Q2 2023 | History |
|---|---|---|---|---|---|
| BMRNBiomarin Pharmaceutical Inc | COM | 142,979 | $12.4M | 4.1% | History |
| CTLTCatalent, Inc. | COM | 241,338 | $10.5M | 3.5% | History |
| SOCSable Offshore Corp. | COM CL A | 443,000 | $4.55M | 1.5% | History |
| RETAReata Pharmaceuticals Inc | CL A | 24,800 | $2.53M | 0.8% | History |